Predicting SARS Mortality with Nasopharyngeal Aspirate
Author Information
Author(s): Tsang Owen Tak-Yin, Chau Tai-Nin, Choi Kin-Wing, Tso Eugene Yuk-Keung, Lim Wilina, Chiu Ming-Chi, Tong Wing-Lok, Lee Po-Oi, Lam Bosco Hoi Shiu, Ng Tak-Keung, Lai Jak-Yiu, Yu Wai-Cho, Lai Sik-To
Primary Institution: Princess Margaret Hospital, Hong Kong
Hypothesis
Is a positive RT-PCR result on nasopharyngeal aspirate samples an independent predictor of death in SARS patients?
Conclusion
A positive RT-PCR result on nasopharyngeal aspirate samples is an independent predictor of higher mortality in SARS patients.
Supporting Evidence
- 156 out of 218 patients tested positive for coronavirus.
- Patients with positive RT-PCR results had higher rates of ICU admission and mechanical ventilation.
- The overall 30-day mortality rate was 10.1%.
Takeaway
If a patient has a positive test for the coronavirus in their nose, they are more likely to get very sick and might not survive.
Methodology
The study compared symptoms and outcomes of 218 patients with suspected SARS, using RT-PCR to test nasopharyngeal aspirate samples.
Potential Biases
Potential for mislabeling non-SARS patients as SARS due to nonspecific symptoms.
Limitations
The study may not account for all variables affecting mortality, and the timing of sample collection could influence RT-PCR results.
Participant Demographics
Majority were Chinese, with a mean age of 39.6 years; included 90 males and 128 females.
Statistical Information
P-Value
0.038
Confidence Interval
1.1 to 38.0
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website